e.l.f. Beauty Is Down 53% From Its All-Time High. Is the Sell-Off an Overreaction?

E.l.f. Beauty’s growth decelerated after FY2024, with net sales growth falling from 77% (FY2024) to 28% (FY2025) and projected just 20% in FY2027. The article attributes margin stability to a shift toward acquisitions and higher costs from inflationary headwinds and tariffs on Chinese products, while reducing China manufacturing dependence from ~100% (2019) to ~75% today. Despite trading at 17x this year’s adjusted EBITDA on a ~$6.8B enterprise value and appearing “historically cheap,” the piece argues the stock likely stagnates unless organic growth re-accelerates.

Analysis

The key market implication is that ELF is migrating from a scarcity-growth story to a normal consumer brand with supply-chain friction. When a company still trades like an above-average grower but the operating profile is drifting toward mid-teens or low-double-digit organic growth, the stock tends to de-rate before the fundamentals fully show up in the quarterlies. The immediate reaction may be muted because the sell-side already sees deceleration, but over the next 1-3 earnings cycles the burden of proof shifts to management to show that acquisitions are additive rather than compensating for slowing core demand.

Second-order, the tariff/sourcing issue matters more than the headline margin print: a 75% China footprint means ELF remains more exposed to policy shocks than peers with broader manufacturing footprints or stronger pricing power. That creates asymmetric downside if freight, tariffs, or FX re-accelerate, because value-skewed consumers are the least tolerant of another round of price increases. Retail partners such as TGT and WMT are unlikely to lose much, but they may become less willing to grant incremental shelf space if the brand no longer drives outsized velocity.

The contrarian case is that the selloff may already reflect too much skepticism if Rhode and other higher-ASP assets can lift mix while China dependence keeps drifting lower. But that upside requires visible organic growth ex-M&A and sustained margin stability; otherwise the stock is just a cheaper version of a slower business. The falsifier is straightforward: if the next 1-2 quarters show re-acceleration in organic sales, stable gross margin, and improved inventory turns, the de-rating thesis should be covered quickly.

Key Decisions for Investors

• Tactically short ELF on any bounce into earnings or retail-channel check seasons; target a 10-15% downside over 1-3 months if organic growth remains sub-20% and management leans on acquisitions.
• Pair trade: long ULTA / short ELF for a 1-3 month relative-value setup; thesis is that ULTA has better pricing power and less tariff sensitivity, while ELF is more exposed to margin compression and shelf-space fatigue.
• If options liquidity is acceptable, buy a 3-6 month ELF put spread instead of outright short stock; use it to express a de-rating view with defined risk in case the market re-rates the stock on any growth re-acceleration.
• Set a cover alert if ELF reports two consecutive quarters of organic growth above the low-teens with China sourcing below ~70%; that would weaken the maturation thesis and likely cap the short.
• Do not overread this into TGT/WMT positioning yet; at current signal strength, the trade is ELF-specific rather than a broad retail call.